8-K
filed May 28, 2026, 4:59 PM ET
ticker RLMD
CIK 0001553643
other
confidence high
sentiment neutral
materiality 0.35
Relmada increases authorized common shares to 200M; stockholders approve 2021 Plan amendment
RELMADA THERAPEUTICS, INC.
- Authorized shares increased from 150M to 200M via charter amendment filed May 28, 2026.
- Annual meeting held May 27: 63.5% of eligible shares voted; directors Casamento and Traversa elected.
- Stockholders ratified CBIZ CPAs P.C. as auditor for FY 2026.
- 2021 Equity Incentive Plan amended to increase available shares by 3M to 18,052,942 total.
- Proposals 1-4 all approved; no material dissent on auditor or charter amendment.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-26-062184
- form_type
- 8-K
- ticker
- RLMD
- cik
- 0001553643
- company_name
- RELMADA THERAPEUTICS, INC.
- filed_at
- 2026-05-28T20:59:47+00:00
- discovered_at
- 2026-05-28T21:02:00.206507+00:00
- generated_at
- 2026-05-28T21:05:16.729164+00:00
- sec_items
- ["5.03", "5.07", "9.01"]
- event_type
- other
- sentiment
- neutral
- materiality_score
- 0.35
- calibrated_materiality_score
- 0.35
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-26-062184
- json_url
- https://secwatch.observer/filing/0001213900-26-062184.json
- markdown_url
- https://secwatch.observer/filing/0001213900-26-062184.md
- text_url
- https://secwatch.observer/filing/0001213900-26-062184.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1553643/000121390026062184/0001213900-26-062184-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1553643/000121390026062184/ea0292521-8k_relmada.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
EDSA
Edesa Biotech shareholders approve equity plan amendment adding 750K shares
Edesa Biotech, Inc.
May 29, 2026, 4:15 PM ET
other
Items 5.02, 5.07, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
OPLN
OPENLANE eliminates Series A Convertible Preferred Stock from charter
OPENLANE, Inc.
May 29, 2026, 1:57 PM ET
other
Items 5.03, 9.01
same SEC item: 5.03, 9.01
same event type: other
similar materiality
Filing page
SEC filing
ONDS
Ondas shareholders approve increase in authorized shares to 1.2B and stock plan pool to 81M shares
Ondas Inc.
May 28, 2026, 4:09 PM ET
other
Items 5.02, 5.07, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
NEXM
NexMetals shareholders elect eight directors, approve auditor and equity plan at AGM
NexMetals Mining Corp.
May 28, 2026, 3:23 PM ET
other
Items 5.07, 7.01, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
HAFC
Director Gideon Yu resigns from Hanmi board; stockholders approve 2026 ESPP
HANMI FINANCIAL CORP
May 27, 2026, 6:15 PM ET
other
Items 5.02, 5.07, 9.01
same SEC item: 5.07, 9.01
same event type: other
similar materiality
Filing page
SEC filing
ILPT
ILPT posts investor presentation with property highlight but no financial updates
Industrial Logistics Properties Trust
June 1, 2026, 4:05 PM ET
other
Items 7.01, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
ETSS
Energy Transition Special Opportunities announces separate trading of ordinary shares and warrants starting June 4, 2026
Energy Transition Special Opportunities
June 1, 2026, 9:09 AM ET
other
Items 8.01, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
AVBC
Avidia Bancorp posts investor presentation for June 2 conference
Avidia Bancorp, Inc.
May 28, 2026, 4:32 PM ET
other
Items 7.01, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.